血管性血友病因子
血小板
凝结
血小板活化
胞外囊泡
化学
微泡
细胞外小泡
细胞生物学
血小板膜糖蛋白
细胞外
糖蛋白
转移
止血
小泡
癌症研究
糖萼
免疫学
中性粒细胞胞外陷阱
P-选择素
循环肿瘤细胞
CD63
血管性血友病
ADAMTS13号
癌症转移
作者
Yuanyuan Wang,Xiaobo Liu,Pascal Nakielski,Katrin Nekipelov,Amanda Salviano‐Silva,Alper Topuz,Alexander Thomas Bauer,Julian Kött,Jannis Akrivakis,Santra Brenna,Tomasz Downar,Neus Feliu,Gerd Bendas,Berta Puig,Stefan W. Schneider,Dmitry A. Fedosov,Christian Gorzelanny
摘要
Plasma proteins are increasingly recognized as key regulators of extracellular vesicle (EV) behaviour in circulation. However, von Willebrand factor (vWF)-the largest multimeric glycoprotein in blood and the only blood protein activated by shear-has received little attention in this context. Under elevated shear stress, vWF transitions from a compact globular form to an extended adhesive conformation. Although elevated plasma vWF levels are associated with hypercoagulation in conditions such as malaria, COVID-19, and cancer, its interactions with EVs or cells under physiological flow have not been systematically investigated. Here, we show that shear-activated vWF functions as a size-selective molecular filter that preferentially captures objects smaller than ∼4 µm, including platelets and tumour-derived EVs, while excluding larger cells. Although intact tumour cells do not directly bind vWF under physiological flow, the coordinated binding of EVs and platelets to extended vWF promotes platelet aggregation, which subsequently traps circulating tumour cells and fosters metastatic dissemination. Our findings reveal a previously unrecognized role of vWF as a shear-dependent EV-binding protein that brings EVs and platelets together to enhance coagulation and metastasis. These EV-vWF-platelet aggregates may represent promising biomarkers or therapeutic targets for the prevention of hypercoagulation in cancer and other thrombo-inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI